Cargando…

Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)

Detalles Bibliográficos
Autor principal: Markers, Disease
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356524/
https://www.ncbi.nlm.nih.gov/pubmed/37476626
http://dx.doi.org/10.1155/2023/9826727
_version_ 1785075297589133312
author Markers, Disease
author_facet Markers, Disease
author_sort Markers, Disease
collection PubMed
description
format Online
Article
Text
id pubmed-10356524
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-103565242023-07-20 Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL) Markers, Disease Dis Markers Retraction Hindawi 2023-07-12 /pmc/articles/PMC10356524/ /pubmed/37476626 http://dx.doi.org/10.1155/2023/9826727 Text en Copyright © 2023 Disease Markers. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Retraction
Markers, Disease
Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title_full Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title_fullStr Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title_full_unstemmed Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title_short Retracted: Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
title_sort retracted: therapy strategy of cd47 in diffuse large b-cell lymphoma (dlbcl)
topic Retraction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356524/
https://www.ncbi.nlm.nih.gov/pubmed/37476626
http://dx.doi.org/10.1155/2023/9826727
work_keys_str_mv AT markersdisease retractedtherapystrategyofcd47indiffuselargebcelllymphomadlbcl